Last reviewed · How we verify

Hypotonic hydration

Memorial University of Newfoundland · FDA-approved active Small molecule

Hypotonic hydration reduces serum osmolality by providing free water, diluting electrolytes and lowering plasma sodium concentration.

Hypotonic hydration reduces serum osmolality by providing free water, diluting electrolytes and lowering plasma sodium concentration. Used for Hypernatremia, Dehydration with hypernatremia, Fluid and electrolyte imbalance.

At a glance

Generic nameHypotonic hydration
Also known asDextrose(5%) in Water
SponsorMemorial University of Newfoundland
ModalitySmall molecule
Therapeutic areaFluid and Electrolyte Management
PhaseFDA-approved

Mechanism of action

Hypotonic hydration involves administration of fluids with lower osmolality than plasma, such as dextrose 5% in water or hypotonic saline solutions. This causes water to move into cells by osmosis, reducing extracellular fluid osmolality and serum sodium levels. It is used therapeutically to treat hypernatremia and certain conditions of fluid and electrolyte imbalance.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: